Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Sialic acid

EU orphan designation number: EU/3/12/972   
Active ingredient: Sialic acid
Indication: Treatment of hereditary inclusion body myopathy
Sponsor: NDA Group AB
Johanneslundsvägen 2, Oxfordhuset, 194 81 Upplands Väsby, Sverige

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/03/2012 Centralised Orphan - Designation EMA/OD/126/11 (2012)1537 of 05/03/2012
02/01/2014 Centralised Orphan - Transfer of orphan designation EMA/OD/126/11/T/01 (2013)9814 of 20/12/2013